SUNREST

Sunrest Lifescience Share Price

₹55.00 +1.5 (2.8%)

03 May, 2025 01:25

SIP TrendupStart SIP in SUNREST

Start SIP

Performance

  • Low
  • ₹54
  • High
  • ₹56
  • 52 Week Low
  • ₹45
  • 52 Week High
  • ₹79
  • Open Price₹54
  • Previous Close₹54
  • Volume11,200

Investment Returns

  • Over 1 Month + 2.33%
  • Over 3 Month -6.78%
  • Over 6 Month -8.33%
  • Over 1 Year -21.71%
SIP Lightning

Smart Investing Starts Here Start SIP with Sunrest Lifescience for Steady Growth!

Invest Now

Sunrest Lifescience Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 104.6
  • PEG Ratio
  • -
  • Market Cap Cr
  • 24
  • P/B Ratio
  • 1.7
  • Average True Range
  • 4.42
  • EPS
  • 0.53
  • Dividend Yield
  • 0
  • MACD Signal
  • -1.27
  • RSI
  • 48.69
  • MFI
  • 69.29

Sunrest Lifescience Financials

Sunrest Lifescience Technicals

EMA & SMA

Current Price
₹55.00
+ 1.5 (2.8%)
pointer
  • stock-down_img
  • Bearish Moving Average 11
  • stock-up_img
  • Bullish Moving Average 5
  • 20 Day
  • ₹55.17
  • 50 Day
  • ₹56.71
  • 100 Day
  • ₹58.67
  • 200 Day
  • ₹63.15

Resistance and Support

54.83 Pivot Speed
  • R3 58.67
  • R2 57.33
  • R1 56.17
  • S1 53.67
  • S2 52.33
  • S3 51.17

What's your outlook on Sunrest Lifescience?

You can only vote for once

Ratings

Master Rating

EPS Strenth

N/A

Price Strength

Buyer Demand

Group Rank

Sunrest Lifescience Ltd has an operating revenue of Rs. 81.99 Cr. on a trailing 12-month basis. An annual revenue growth of 19% is outstanding, Pre-tax margin of 2% needs improvement, ROE of 1% is fair but needs improvement. The company has a reasonable debt to equity of 24%, which signals a healthy balance sheet. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 50 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 139 indicates it belongs to a poor industry group of Medical-Supplies and a Master Score of E is the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Sunrest Lifescience Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-14 Quarterly Results
2024-05-27 Audited Results

Sunrest Lifescience F&O

Sunrest Lifescience Shareholding Pattern

69.91%
24.95%
5.14%

About Sunrest Lifescience

  • NSE Symbol
  • SUNREST
  • BSE Symbol
  • Managing Director
  • Mr. Nikhilkumar Yashvntlal Thakkar
  • ISIN
  • INE0PLZ01012

Similar Stocks to Sunrest Lifescience

Sunrest Lifescience FAQs

Sunrest Lifescience share price is ₹55 As on 03 May, 2025 | 01:11

The Market Cap of Sunrest Lifescience is ₹23.6 Cr As on 03 May, 2025 | 01:11

The P/E ratio of Sunrest Lifescience is 104.6 As on 03 May, 2025 | 01:11

The PB ratio of Sunrest Lifescience is 1.7 As on 03 May, 2025 | 01:11

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23